To Get Help Now
Click Here
 
Today's Date:

Dr. Oz Features the Story of a Pennsylvania Woman Who Blames Cell Phones for her Breast Cancer

Popular physician and television star Dr. Mehmet Oz is warning women that carrying cell phones in their bras could lead to breast cancer.

On the August 26 episode of The Dr. Oz Show, Dr. Oz warned his female viewers that carrying a cell phone in your bra could put you at greater risk for breast cancer. The nation’s most well-known doctor firmly believes there is a link between cell phone use and cancer, according to Examiner.com. More Dr. Oz Features the Story of a Pennsylvania Woman Who Blames Cell Phones for her Breast Cancer

Researchers Investigating Links Between Chemicals in the Environment and Diabetes

Researchers from the University of Buffalo in Buffalo, New York, are on the search for data that links chemicals in the environment to an increased risk of diabetes.

Scientists from the university are studying whether chemicals in the environment increase the risk of metabolic conditions by disrupting neuroendocrine circadian functions and altering the release of hormones, including insulin, according to the University of Buffalo’s School of Medicine and Biomedical Sciences (SMBS) website. More Researchers Investigating Links Between Chemicals in the Environment and Diabetes

Teva Recalling Parkinson’s Drug Due to Potency Concerns

The U.S. Food and Drug Administration (FDA) announced Teva Pharmaceutical Industries is recalling one lot of its generic Parkinson’s combo drug carbidopa/levodopa because of concerns that it could contain too much of an active pharmaceutical ingredient.

The recall FDA labeled the recall as Class II status. Teva said the recall, which is nationwide, involved 3,881 bottles of carbidopa/levodopa 25 mg/100 mg. The company issued the recall out of precaution after stability testing found that the product might be super-potent, according to FiercePharmanufacturing.com. More Teva Recalling Parkinson’s Drug Due to Potency Concerns

FDA Orders BioAnue Laboratories to Terminate Sales of Supplements

A federal court has ordered the dietary supplement manufacturer BioAnue Laboratories to stop illegally marketing its products as treatments for disease and to terminate the sale of supplements.

The order will remain intact until the company complies with the U.S. Food and Drug Administration’s (FDA) manufacturing regulations and other requirements. A federal judge issued the order against BioAnue Laboratories of Rochelle, Georgia, and its owner/operators, Gloria and Kelly Raber, according to the FDA notice. More FDA Orders BioAnue Laboratories to Terminate Sales of Supplements

CDC Manipulated Study Data to Negate a Link Between Autism and Immunizations in African-American Boys

A whistleblower says federal health officials have been manipulating data that shows a link between the MMR (measles, mumps, rubella) vaccination and autism in a certain population.

According to a study by the Focus Autism Foundation, a top scientists working for the U.S. Centers for Disease Control and Prevention (CDC) helped Dr. Brian Hooker of the Focus Autism Foundation uncover data manipulated by the CDC that revealed a higher rate of autism among African-American boys, according to Organic Lifestyle Magazine. More CDC Manipulated Study Data to Negate a Link Between Autism and Immunizations in African-American Boys

Hydrocodone Combination Products Reclassified as Schedule II Drugs

The U.S. Drug Enforcement Administration (DEA) is following the recommendation by the U.S. Food and Drug Administration (FDA) to begin regulating all hydrocodone combination products as Schedule II drugs under federal law.

The rule, which will come into effect in 45 days, will impact some of the U.S.’s most popular painkillers, including Vicodin. More Hydrocodone Combination Products Reclassified as Schedule II Drugs

Drug Enforcement Administration (DEA) will Regulate All Hydrocodone Combination Products Starting in Early October

Acting on an October 2013 recommendation by the U.S. Food and Drug Administration (FDA), the U.S. Drug Enforcement Administration (DEA) announced August 21 that it will regulate all hydrocodone combination products as Schedule II drugs under federal law.

The Controlled Substances Act (CSA) of 1970 places controls on dangerous and addictive drugs, and drugs lacking medically-accepted uses, according to RAPS.org. More Drug Enforcement Administration (DEA) will Regulate All Hydrocodone Combination Products Starting in Early October

Whistleblower: CDC Hid MMR Vaccine’s Link to Autism in African American Boys

A whistleblower at the U.S. Center for Disease Control and Prevention (CDC) said there has been manipulation of scientific data involving the MMR (measles, mumps, rubella) vaccine, according to a study by Focus Autism Foundation.
The manipulation of data took place because there was pressure from the top to get CDC scientists to back government policies on vaccine safety while ignoring and hiding the risks involved, the whistleblower said. More Whistleblower: CDC Hid MMR Vaccine’s Link to Autism in African American Boys

Antibiotic May Increase Heart Risks and Death

Taking the antibiotic clarithromycin may increase some patients’ odds of dying from heart-related causes, according to a new study conducted by Danish researchers.

While the risk is small, the antibiotic is taken by millions of people across the globe take the antibiotic, so the findings should be taken quite seriously. Clarithromycin – as well as another antibiotic called roxithromycin – are in a group of antibiotics called macrolides. The researchers believe that macrolides elevate the risk of potentially deadly heart rhythm problems. More Antibiotic May Increase Heart Risks and Death

Defective Saline Sheaths Prompt Recall of Atherectomy Systems

The U.S. Food and Drug Administration (FDA) announced that Cardiovascular Systems is recalling certain lots of the Diamondback 360 Peripheral Orbital Atherectomy Systems because they contain defective saline sheaths that could fracture during use.

The Diamondback 360 Peripheral Orbital Atherectomy System is a high-speed cutting tool inserted through a catheter into a patient’s blood vessel. The system is intended to reestablish blood flow in narrowed arteries or arterio-venous dialysis shunts. More Defective Saline Sheaths Prompt Recall of Atherectomy Systems